(For a Reuters live blog on U.S., UK and European stock

markets, click or type LIVE/ in a news window)

April 4 (Reuters) - European stocks edged higher on

Thursday with investors awaiting an inflation print and minutes

from the European Central Bank's latest meeting, while shares of

Basilea jumped following the U.S. regulatory approval for the

drugmaker's bacterial therapy.

The continent-wide STOXX 600 index was up 0.1%, as

of 0720 GMT, ahead of the region's February producer prices due

at 0900 GMT.

The producer prices index is likely to decline 8.6%,

unchanged from January, according to economists polled by

Reuters.

Later in the day, investors will parse minutes from ECB's

March meeting to ascertain the timing of the much-awaited first

interest rate cut.

Among early movers, Basilea Pharmaceutica surged

9.4% to an over six-month high after the Swiss firm received

U.S. health regulator's approval for its antibiotic Zevtera that

treats bacterial infections including multidrug-resistant

strains.

Shares of Compugroup gained 7.5% after Morgan

Stanley upgraded the German medical software company's stock

rating to "overweight" from "equal-weight".